A detailed history of Argentarii, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Argentarii, LLC holds 7,927 shares of MRK stock, worth $736,101. This represents 0.27% of its overall portfolio holdings.

Number of Shares
7,927
Previous 9,723 18.47%
Holding current value
$736,101
Previous $816 Million 2.25%
% of portfolio
0.27%
Previous 0.33%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 13, 2026

SELL
$82.49 - $92.93 $148,152 - $166,902
-1,796 Reduced 18.47%
7,927 $834 Million
Q3 2025

Oct 27, 2025

BUY
$77.6 - $87.37 $7,527 - $8,474
97 Added 1.01%
9,723 $816 Million
Q2 2025

Jul 14, 2025

BUY
$73.47 - $87.12 $159,944 - $189,660
2,177 Added 29.23%
9,626 $762 Million
Q1 2025

Apr 29, 2025

BUY
$83.01 - $101.02 $292,444 - $355,893
3,523 Added 89.74%
7,449 $669 Million
Q4 2024

Feb 07, 2025

BUY
$96.31 - $114.76 $378,113 - $450,547
3,926 New
3,926 $391 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $235B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Argentarii, LLC Portfolio

Follow Argentarii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argentarii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argentarii, LLC with notifications on news.